Patients with primary biliary cirrhosis have increased serum total antioxidant capacity measured with the crocin bleaching assay

doi:10.3748/wjg.v11.i27.4194

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 27

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2573)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

253

HTML

1989

Figures (1-4)

189

Tables (1-3)

142

Sum=2573

Jul 21, 2005 (publication date) through Jul 26, 2024

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. Jul 21, 2005; 11(27): 4194-4198
Published online Jul 21, 2005. doi: 10.3748/wjg.v11.i27.4194

Full Size Figure Download Figure

Figure 3 UDCA treatment reduces TAC and CTAC values. A significant reduction of CTAC was observed in the early stages of PBC. In late stages, a reduction of CTAC was also noted but this was at the limit of statistical significance. ^bP < 0.001 vs TAC.

Citation: Notas G, Miliaraki N, Kampa M, Dimoulios F, Matrella E, Hatzidakis A, Castanas E, Kouroumalis E. Patients with primary biliary cirrhosis have increased serum total antioxidant capacity measured with the crocin bleaching assay. World J Gastroenterol 2005; 11(27): 4194-4198
URL: https://www.wjgnet.com/1007-9327/full/v11/i27/4194.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i27.4194